360 related articles for article (PubMed ID: 11544343)
1. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
[TBL] [Abstract][Full Text] [Related]
3. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig.
Koga S; Auerbach MB; Engeman TM; Novick AC; Toma H; Fairchild RL
J Immunol; 1999 Nov; 163(9):4878-85. PubMed ID: 10528189
[TBL] [Abstract][Full Text] [Related]
4. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts.
Watarai Y; Koga S; Paolone DR; Engeman TM; Tannenbaum C; Hamilton TA; Fairchild RL
J Immunol; 2000 Jun; 164(11):6027-33. PubMed ID: 10820287
[TBL] [Abstract][Full Text] [Related]
5. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
[TBL] [Abstract][Full Text] [Related]
6. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
7. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
8. Donor-derived IP-10 initiates development of acute allograft rejection.
Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
[TBL] [Abstract][Full Text] [Related]
9. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
[TBL] [Abstract][Full Text] [Related]
10. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
Kobayashi H; Novick AC; Toma H; Fairchild RL
Transplantation; 2002 Aug; 74(3):387-95. PubMed ID: 12177619
[TBL] [Abstract][Full Text] [Related]
11. Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells.
Kapoor A; Morita K; Engeman TM; Koga S; Vapnek EM; Hobart MG; Fairchild RL
Transplantation; 2000 Mar; 69(6):1147-55. PubMed ID: 10762220
[TBL] [Abstract][Full Text] [Related]
12. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
[TBL] [Abstract][Full Text] [Related]
13. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
[TBL] [Abstract][Full Text] [Related]
14. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts.
Fahmy NM; Yamani MH; Starling RC; Ratliff NB; Young JB; McCarthy PM; Feng J; Novick AC; Fairchild RL
Transplantation; 2003 Jun; 75(12):2044-7. PubMed ID: 12829909
[TBL] [Abstract][Full Text] [Related]
15. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
Zhang QW; Kish DD; Fairchild RL
J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
[TBL] [Abstract][Full Text] [Related]
16. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
Hildebrandt GC; Corrion LA; Olkiewicz KM; Lu B; Lowler K; Duffner UA; Moore BB; Kuziel WA; Liu C; Cooke KR
J Immunol; 2004 Aug; 173(3):2050-9. PubMed ID: 15265940
[TBL] [Abstract][Full Text] [Related]
17. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.
Jiankuo M; Xingbing W; Baojun H; Xiongwin W; Zhuoya L; Ping X; Yong X; Anting L; Chunsong H; Feili G; Jinquan T
J Immunol; 2003 Feb; 170(3):1556-65. PubMed ID: 12538721
[TBL] [Abstract][Full Text] [Related]
18. Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
Hancock WW; Lu B; Gao W; Csizmadia V; Faia K; King JA; Smiley ST; Ling M; Gerard NP; Gerard C
J Exp Med; 2000 Nov; 192(10):1515-20. PubMed ID: 11085753
[TBL] [Abstract][Full Text] [Related]
19. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
20. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.
Melter M; Exeni A; Reinders ME; Fang JC; McMahon G; Ganz P; Hancock WW; Briscoe DM
Circulation; 2001 Nov; 104(21):2558-64. PubMed ID: 11714650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
